Viewing StudyNCT00070187



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00070187
Status: COMPLETED
Last Update Posted: 2013-10-17
First Post: 2003-10-03

Brief Title: Immunotherapy Using Cyclosporine Interferon Gamma and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkins Lymphoma
Sponsor: Childrens Oncology Group
Organization: Childrens Oncology Group

Organization Data

Organization: Childrens Oncology Group
Class: NETWORK
Study ID: AHOD0121
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Childrens Oncology Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH